DT
DiaMedica Therapeutics Inc.
SEC filingBiotechnology · Minneapolis, MN
Amount raised$30.1Msold at filing
Total offering$30.1M
Investors in the raise14count reported to the SEC
FiledJul 25, 2025first sale Jul 23, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David J. WambekeExecutive Officer
Charles P. SembaDirector
Lorianne MasuokaExecutive Officer
Daniel T. O'ConnorDirector
Scott KellenExecutive Officer
Richard R. KuntzDirector
Michael R. GiuffreDirector
Tanya N. LewisDirector
Rick PaulsExecutive Officer, Director
James T. ParsonsDirector
Executive officers, directors and promoters as listed on the Form D.